HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Speaker at Drug Delivery Events - Miroslav Radenkovic
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Pulmonary arterial hypertension (PAH) remains a devastating disease with high morbidity and mortality. It is uncommon, progressive and life-threatening blood vessel disorder differentiated by the constriction of minor pulmonary arteries and elevated blood pressure in the pulmonar [....] » Read More

Speaker at Pharmaceutical Conference - Srividya Narayanan
Oral Presentation (In-Person)
Srividya Narayanan, Northeastern University, United States

Nanotechnology has revolutionized pharmaceutical and biomedical applications, offering a plethora of opportunities in drug delivery, medical imaging, and cancer therapy. However, the unique properties of nanomaterials present significant regulatory challenges that must be address [....] » Read More

Speaker at Pharmaceutical Conference - Eman Shalaby
Oral Presentation (In-Person)
Eman Shalaby, National Research Centre, Egypt

Photoaging is one of the most common issues in the world, affecting nearly all women. The term "photoaging" describes the early aging of skin brought on by excessive exposure to ultraviolet radiation. Our study's objective was to evaluate Allantoin proposomes' a [....] » Read More

Speaker at Drug Delivery Events - Hashem M Mansour
Oral Presentation (In-Person)
Hashem M Mansour, Indonesian Hospital, State of Palestine

Background: In this study, we analysed the data on antimicrobial resistance in the bloodstream. This study aims to evaluate the bacterial resistance in the Gaza Strip and compare with that in other countries. Methods: This study was conducted retrospectively in the Indonesian [....] » Read More

Speaker at Drug Delivery Events - Haitham A Saleh
Poster Presentation (In-Person)
Haitham A Saleh, Qatar University, Qatar

Diabetes mellitus is a chronic disease characterized by metabolic defects, including insulin deficiency and resistance. Individuals with diabetes are at increased risk of developing cardiovascular complications, such as atherosclerosis, coronary artery disease, and hypertension. [....] » Read More

Speaker at Pharmaceutical Conference - Consolato M Sergi
Keynote Presentation (Virtual)
Consolato M Sergi, Universities of Alberta and Ottawa, Canada

Introduction: Metabolic-(non-alcoholic) associated fatty liver disease (MAFLD/NAFLD) has increasingly become a worldwide epidemic. It has been suggested that renaming NAFLD to MAFLD is critical in identifying patients with advanced fibrosis and poor cardiovascular outcomes. There [....] » Read More

Speaker at Pharma Conferences - Gurpreet Singh
Oral Presentation (Virtual)
Gurpreet Singh, IQVIA, United Kingdom

The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical Companies based on projected R&D spending in 2026 are Roche, Johnson & Johnson, Merck & [....] » Read More

Scientific Programs coming soon..

Watsapp